Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel +/- Trastuzumab After Stem Cell Transplant in Refractory Metastatic Breast Cancer
NCT00004013Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 1999
- Primary completion
- Oct 2001
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, trastuzumab in breast cancer, sponsored by Fred Hutchinson Cancer Center. Started Jan 1999; status: completed.
02
Drugs
paclitaxeltrastuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004013.